Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.

Cell - 30 Sept 2021

Cevik Muge, Grubaugh Nathan D, Iwasaki Akiko, Openshaw Peter

Abstract excerpt

As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral
Share to COVID-19 Vaccines

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunity, Cellular

Share to Immunogenicity, Vaccine

Share to Pandemics

Share to SARS-CoV-2

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 34534444
DOI: 10.1016/j.cell.2021.09.010
PMCID: PMC8445744

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.PMID 34534444Read ↗

A review of leading COVID-19 vaccines, the quest for immune protection, and its key challenges. Part 3: Covid-19 vaccines – Key challenges and translational scienceSemantic proximity Read ↗

Immune variants of SARS-CoV-2 could be a significant challenge for developing a pan genotype-specific vaccine.Semantic proximity Read ↗

T Cell Responses to SARS-CoV-2Semantic proximity Read ↗

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19Semantic proximity Read ↗

An Overview of the Immune Response to COVID-19 Vaccination and Strategies to Boost SARS-CoV-2 Immunity in People with Inborn Errors of ImmunitySemantic proximity Read ↗

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants.Semantic proximity Read ↗

Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines.Semantic proximity Read ↗

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum ProtectionSemantic proximity Read ↗

COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte.Semantic proximity Read ↗

Essential Considerations During Vaccine Design against COVID-19 and Review of Pioneering Vaccine Candidate PlatformsSemantic proximity Read ↗

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern.Semantic proximity Read ↗

The T cell immune response against SARS-CoV-2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.